Skip to main content
Download PDF

Erratum to: Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors

Retrovirology volume 6, Article number: 33 (2009) Cite this article

The Original Article was published on 05 March 2009

Abstract

Correction to Erik Serrao, Srinivas Odde, Kavya Ramkumar and Nouri Neamati: Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors. Retrovirology 2009, 6:25. Since the recent publication of our article (Neamati, Retrovirology 2009, 6:25), we have noticed an error which we would like to correct and we would like to apologise to the readers for this mistake.

Correction

The structure of BMS-707035 has not been publicly released. In Figure one on page 2 and a discussion on page 5 of our published paper [1], we mistakenly assigned a structure and activity data to BMS-707035. The structure and activity data that we mentioned actually belong to a different compound from the same group. The resistance pattern of BMS-707035 is "overlapping" rather than identical to raltegravir. Please see the following references [2, 3] for a detailed description of their development of pyrimidine carboxamides.

References

  1. Serrao Erik, Odde Srinivas, Ramkumar Kavya, Neamati Nouri: Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors. Retrovirology. 2009, 6: 25-10.1186/1742-4690-6-25.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Dicker IB, Samanta HK, Li Z, Hong Y, Tian Y, Banville J, Remillard RR, Walker MA, Langley DR, Krystal M: Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors. J Biol Chem. 2007, 282 (43): 31186-96. 10.1074/jbc.M704935200.

    Article  CAS  PubMed  Google Scholar 

  3. Dicker IB, Terry B, Lin Z, Li Z, Bollini S, Samanta HK, Gali V, Walker MA, Krystal MR: Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors. J Biol Chem. 2008, 283 (35): 23599-609. 10.1074/jbc.M804213200.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, School of Pharmacy, 1985 Zonal Avenue, Los Angeles, CA, 90089, USA

    Erik Serrao, Srinivas Odde, Kavya Ramkumar & Nouri Neamati

Authors
  1. Erik Serrao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Srinivas Odde
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kavya Ramkumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nouri Neamati
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nouri Neamati.

Additional information

The online version of the original article can be found at 10.1186/1742-4690-6-25

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Serrao, E., Odde, S., Ramkumar, K. et al. Erratum to: Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors. Retrovirology 6, 33 (2009). https://doi.org/10.1186/1742-4690-6-33

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/1742-4690-6-33

Retrovirology

ISSN: 1742-4690

Contact us